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ABSTRACT: How can you use a ruthenium isomerization catalyst twice? A ruthenium-catalyzed sequence for the formal two-
carbon scission of allyl groups to carboxylic acids has been developed. The reaction includes an initial isomerization step using 
commercially available ruthenium catalysts followed by in situ transformation of the complex to a metal-oxo species, which is ca-
pable of catalyzing subsequent oxidation reactions. The method enables enantioselective syntheses of challenging α-tri- and 
tetrasubstituted α-amino acids including an expedient total synthesis of the antiepileptic drug levetiracetam. 
INTRODUCTION  
The use of a single metal catalyst for several chemical trans-
formations in a one-pot and/or a sequential manner1 is highly 
desirable due to high material cost and limited resources of 
transition metals.2 Moreover, new tools for modifying preva-
lent functional groups, which are easily installed in a chemo- 
and stereoselective fashion, are needed to expand the applica-
tion of novel methodology in both academic and industrial 
settings.3 In this context, allyl groups are ubiquitous and their 
introduction is very well established including asymmetric 
additions.4 In general, three modes for their installation can be 
distinguished (Figure 1): As a nucleophile5,6 (e.g. Grignard 
addition7), as an electrophile8 (e.g. Tsuji-Trost allylation9) or 
as a formally neutral species10 (e.g. Keck radical allylation11). 
 
Figure 1. General modes for the introduction of allyl groups.  
Most of these methods not only find widespread use in or-
ganic synthesis, but also allow for the installation of allyl 
groups in a highly stereoselective fashion, even to build chal-
lenging chiral quaternary stereocenters.12 However, tools for 
the formal scission of two carbons of an allyl group leading to 
a truncated carboxylic acid using a single transition metal cata-
lyst have, to our knowledge, not been described (Scheme 1A, 
M1=M2). The use of only one catalyst is in strong contrast to 
the field of one-pot catalysis, where for instance two transition 
metal catalysts are used for isomerization/metathesis reac-
tions.13  
 
Scheme 1: Sequences and methods for the introduction of chiral 
carboxylic acid groups. 
Although a sequence involving vinylation followed by oxi-
dative cleavage of the double bond would in theory lead to the 
same carboxylic acid product, asymmetric vinylation reactions 
are far less established than allylations (Scheme 1B).4 In par-
ticular, catalytic enantioselective vinylation of carbonyl eno-
lates is still highly challenging and limited in substrate scope 
and, moreover, methods for the construction of quaternary 
stereocenters are very rare.12,14 Even more scarce and far less 
established are catalytic enantioselective carboxylations 
(Scheme 1C).15 
As a result, we focused our attention on the catalytic oxida-
tive scission of two carbons from the tail of an allyl unit in 
order to render such groups as carboxylic acid synthesis 
equivalents (Scheme 2). Herein, we present the results of that 
study and provide illustrative examples of this new method in 
the context of high value and unusual amino acid synthesis.  
RESULTS AND DISCUSSION 
After exploring a variety of transition metal catalysts known 
for alkene isomerization (iridium, rhodium, palladium, ruthe-
nium; for details see the Supporting Information), we found 
that ruthenium catalysts performed best and were amenable to 
further oxidative catalysis (Scheme 2). 
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Scheme 2. Ruthenium-catalyzed two-carbon truncation of allyl 
groups to carboxylic acids. 
In particular, the commercially available Grubbs second 
generation catalyst 1a (Figure 2) under Nishida’s conditions16 
was highly chemoselective for alkene isomerization and dis-
played good conversion (>90%) without noticeable side reac-
tions. Moreover, we discovered that the in situ formed Ru–H 
complex17 1b, after solvent exchange, can be oxidized with 
NaIO4 to an oxidized ruthenium species,18 which is capable of 
catalyzing subsequent oxidation reactions (e.g. oxidative 
cleavage of alkenes, Scheme 2).19 It has to be reinforced at this 
point that we do not add a new external ruthenium source for 
the second step. Instead, the crude transition metal catalyst 
from the previous isomerization step is modified in situ and 
reused for the catalytic oxidation reactions. Moreover, the only 
operation between the two steps is evaporation of the solvent 
from the isomerization reaction (toluene for 1a, acetone for 2) 
followed by dissolution of the crude reaction mixture in the 
solvent mixture used for oxidation (CCl4, MeCN, H2O). 
 
Figure 2. Identified ruthenium catalysts for olefin isomeriza-
tion/oxidation sequences – An in situ formed ruthenium-hydride 
complex 1b derived from Grubbs second generation catalyst (1a) 
and Grotjahn’s catalyst (2). 
Even though NaIO4 mediated oxidations of ruthenium al-
kylidene complexes and their use in sequential and tandem 
catalysis19b,20 have been described previously (e.g. 
RCM/dihydroxylation),21 the modification and multiple use13 
of a ruthenium-hydride complex17 1b (derived from precata-
lyst 1a) or a ruthenium phosphine-imidazole complex22 2 in an 
isomerization/oxidation sequence was not known, until now 
(Figure 2). 
Hence, chiral homoallylic amine 3, which was readily syn-
thesized via diastereoselective allylation of Ellman’s sulfin-
imine,5e was subjected to the optimized conditions using 
Grubbs catalyst 1a giving the isomerized alkene in 98% con-
version (Scheme 3A). After oxidation of the crude catalyst, an 
alkene cleavage/sulfinamide oxidation duet23 took place fur-
nishing Bus-protected24 D-tert-leucine (4) in 72% yield over 2 
steps, notably without racemization (99% ee). The Bus pro-
tected amino acid 4 can be employed directly for a peptide 
coupling as reported by Hanessian,24 or the Bus group is readi-
ly cleaved under acidic conditions to afford D-tert-leucine (5) 
in 96% yield (98% ee) after ion exchange chromatography.  
Alternatively, by leaving out the olefin isomerization, sul-
finamide 3 was subjected to a similar alkene cleav-
age/sulfinamide oxidation sequence with a catalytic amount of 
RuCl3 hydrate giving Bus-protected β-amino acid 6 in 93% 
yield (Scheme 3B). After deprotection and ion exchange 
chromatography, (S)-β-neopentylglycine (7) was obtained in 
91% yield and 98% ee. Benzoyl protected amine 8, which is 
accessible in enantiopure form using Schaus’ allylboration,25 
performed equally well in our sequential ruthenium catalysis, 
affording carboxylic acid 9 in 88% yield over 2 steps (Scheme 
3C). Benzoyl deprotection with aqueous HCl in methanol pro-
vided racemic tert-leucine (5) in 57% yield.  
 
Scheme 3. a) 1. Grubbs 1a (5 mol%), VTMS, toluene, reflux, 21 
h, 98% conv., E/Z 4.4:1; 2. NaIO4, CCl4, MeCN, H2O, 23°C, 2.5 
d, 72% yield over 2 steps, 99% ee; b) 1. TfOH, CH2Cl2, 0°C, 2.5 
h; 2. IEC, 96% yield, 98% ee; c) RuCl3H2O (5 mol%), NaIO4, 
CCl4, MeCN, H2O, 23°C, 16 h, 93% yield; d) 1. TfOH, CH2Cl2, 
0°C→23°C, 2 d; 2) IEC, 91% yield, 98% ee; e) 1. Grubbs 1a (5 
mol%), VTMS, toluene, 128°C, 16 h, 97% conv., E/Z 4:1; 2. 
NaIO4, CCl4, MeCN, H2O, 23°C, 22 h, 88% yield over 2 steps; f) 
1. 4 M aq. HCl, MeOH, reflux, 24 h; 2. IEC, 57% yield; g) 1. 
Grubbs 1a (5 mol%), VTMS, toluene, 128°C, 18 h, 92% conv., 
E/Z 4.5:1; 2. NaIO4, CCl4, MeCN, H2O, 23°C, 24 h, 62% yield 
over 2 steps; h) ClCO2Et, NEt3, THF, then NH4OH, 0°C→23°C, 
19 h, 67% yield, >98% ee. IEC=ion exchange chromatography, 
VTMS=vinyloxy trimethylsilane. 
The sequential ruthenium catalysis was then used for an en-
antioselective total synthesis of levetiracetam (12), the active 
pharmaceutical ingredient of the antiepileptic medicine Kep-
pra® (Scheme 3D).26 The synthesis commenced from homoal-
lylic amide 10, which was prepared in four steps from com-
mercially available propionaldehyde and Ellman’s auxiliary5e 
(see the Supporting Information for details). Sequential ruthe-
nium catalysis of alkene 10 with Grubbs catalyst 1a provided 
access to carboxylic acid 11 in 62% yield over two steps. 
Amidation of 11 was achieved via the corresponding mixed 
anhydride and reaction with ammonium hydroxide as de-
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 scribed previously by Sánchez.27 Levetiracetam (12) was iso-
lated in 67% yield (>98% ee) and, after one recrystallization, 
was enriched to excellent enantiopurity (>99.9% ee). 
 
Scheme 4. a) 15: 1. Grubbs 1a (5 mol%), VTMS, toluene, 
130°C, 18 h, 88% conv.; 2. NaIO4, CCl4, MeCN, H2O, 23°C; 
3. DPPA, NEt3, MeCN, 0°C→65°C, 3 h, 27% yield over 3 
steps; 16: 1. Grubbs 1a (5 mol%), VTMS, toluene, 125°C, 16 
h, 96% conv. or Grotjahn 2 (2 mol%), acetone-d6, 70°C, 63 h, 
95% conv.; 2. NaIO4, CCl4, MeCN, H2O, 23°C, 3. DPPA, 
NEt3, MeCN, 0°C→65°C, 47% yield over 3 steps (with 1a) 
and 52% yield over 3 steps (with 2); b) 17: 1. 4 M aq. HCl, 
1,4-dioxane, 120°C, 12 h; 2. IEC, 61% yield; 18: 1. 2 M aq. 
HCl, THF, reflux, 24 h; 2. IEC, 95% yield; c) 1. Grubbs 1a (5 
mol%), VTMS, toluene, 129°C, 21 h, 96% conv., 2. NaIO4, 
CCl4, MeCN, H2O, 23°C, 24 h; 3. DPPA, NEt3, MeCN, 
0°C→65°C, 3 h, 65% yield over 3 steps; d) 1. 4 M aq. HCl, 
dioxane, reflux, 18 h; 2. IEC, 92% yield; e) 1. Grubbs 1a (5 
mol%), VTMS, toluene, 129°C, 21 h, 93% conv.; 2. NaIO4, 
CCl4, MeCN, H2O, 23°C, 25 h; 3. DPPA, NEt3, MeCN, 
0°C→65°C, 3 h, 34% yield over 3 steps; f) 1. 4 M aq. HCl, 
dioxane, reflux, 18 h; 2. IEC, 99% yield. DPPA=diphenyl 
phosphoryl azide, IEC=ion exchange chromatography, 
VTMS=vinyloxy trimethylsilane. 
We next applied our sequential ruthenium catalysis condi-
tions to α-quaternary lactams (Scheme 4), which were readily 
available in enantiopure form using palladium-catalyzed de-
carboxylative allylic alkylation.8a,28 The unprotected methyl- 
and ethyl-substituted lactams 13 and 14 were treated with a 
catalytic amount of Grubbs catalyst 1a and the internal alkene 
was subsequently cleaved to give the crude carboxylic acids. 
A Curtius rearrangement29 then furnished isocyanates 15 and 
16 in 27% and 47% yield over 3 steps, respectively.30 Like-
wise, we found that 2 mol% of Grotjahn’s catalyst22 (2, Figure 
2) worked equally well31 for the ruthenium-catalyzed isomeri-
zation/oxidation sequence of lactam 14 to give, after Curtius 
rearrangement, isocyanate 16 in a comparable 52% yield over 
3 steps.32 Hydrolysis of the isocyanate and the amide bond of 
15 and 16 were achieved under acidic conditions to give ac-
cess to enantiopure (R)-α-methylornithine33 (17) and (R)-α-
ethylornithine34 (18) in 61% and 95% yield, respectively. The 
latter has been synthesized for the first time as a single enanti-
omer.
34
 Biologically, both α -alkyl ornithine analogs are 
known to be ornithine decarboxylase inhibitors.33a,34  
Treatment of caprolactam 19 and glutarimide 22 with cata-
lyst 1a under our optimized conditions gave, after Curtius 
rearrangement, hydantoin 20 and isocyanate 23 in 65% and 
34% yield over 3 steps, respectively. Anti-Bredt bicycle35-37 
20 results from an intramolecular cyclization of the lactam NH 
to the isocyanate. Its structure was unambiguously confirmed 
by X-ray crystallography (see the Supporting Information). 
Subsequent hydrolysis of 20 and 23 with aqueous HCl fur-
nished (R)-α-methyllysine33d (21) and (R)-α-methylglutamic 
acid33c,38 (24), respectively, in excellent yields (92% and 
99%). Given the recent availability of α-quaternary lactams 
and imides,28 it is possible to envision the synthesis of a wide 
range of α-substituted amino acid derivatives for a multitude 
of applications.  
 
Scheme 5. a) DPPA, NEt3, DCE, 23°C→reflux, 5 h, then 
BnOH, reflux, 38 h, 29% yield, 98% ee; b) H2, Pd/C, MeOH, 
23°C, 4 h, >99% yield; c) LiAlH4, THF, 0°C→reflux, 24 h, 
then HCl/dioxane, 89% yield. DCE=1,2-dichloroethane, 
DPPA= diphenyl phosphoryl azide. 
The enantioenriched carboxylic acid 25, obtained by our 
Ru-catalyzed isomerization oxidation method on lactam 14 
(Scheme 4), is not only an intermediate in Padwa’s racemic 
synthesis of desacetoxy-4-oxo-6,7-dihydrovindoro-sine39 (29), 
but can also be used for the synthesis of Cbz-protected α-
amino lactam 26 (98% ee) by trapping the intermediate isocy-
anate 16 with benzyl alcohol following the Curtius rearrange-
ment (Scheme 5). Hydrogenolysis of the Cbz group gave ami-
no lactam 27 in quantitative yield, which renders Knabe’s 
racemic synthesis of 3-ethyl thalidomide40 (30) enantioselec-
tive. Reduction of lactam 27 with LiAlH4, followed by pre-
cipitation as the bishydrochloride salt furnished chiral diamine 
28 in 89% yield. The racemic, mono-Boc protected version of 
28 was used recently by Nishio et al.41 for the synthesis of 
dipeptidyl peptidase IV (DPP-4) inhibitors. 
CONCLUSIONS 
In summary, we have developed a highly efficient rutheni-
um catalyzed isomerization/oxidation sequence, which ena-
bled the syntheses of challenging unnatural amino acids such 
as D-tert-leucine (5), (S)-β -neopentylglycine (7), (R)-α -
methyl- and ethylornithine (17 and 18), (R)-α-methyllysine 
(21) and (R)-α-methylglutamic acid (24). The reaction se-
quence performs well with not only ruthenium-hydride com-
plex 1b (derived from Grubbs catalyst 1a), but also with the 
less common Grotjahn catalyst 2. We found that both isomeri-
zation catalysts 1b and 2 can be used to perform one or several 
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 subsequent oxidation steps after NaIO4 treatment of the crude 
reaction mixtures. To demonstrate the utility of our method, 
we have completed an enantioselective total synthesis of the 
antiepileptic drug levetiracetam (12) and enantioselective for-
mal syntheses of a vindorosine derivative 29 and of (R)-3-
ethyl thalidomide (30). Given the importance and ubiquity of 
the amino acid subunit in organic chemistry, we believe that 
our method will inspire many creative permutations and appli-
cations. Further usages of the method are currently under in-
vestigation. 
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